Albaad Massuot Yitzhak Ltd. (IL:ALBA)
TASE:ALBA
Top Page
Albaad
(TASE:ALBA)
Select Model
Select Model
Rating:63Neutral
Price Target:
3,281.00
▼(-9.71% Downside)
Action:DowngradedDate:03/14/26
Overall score reflects a mix of attractive valuation (low P/E and solid dividend) and improving operating performance, offset by elevated leverage and inconsistent cash-flow conversion, alongside weak technical momentum and a below-key-moving-averages price trend.
Positive Factors
Diversified revenue streams
Albaad's business spans finished disposable hygiene products and nonwoven materials sold to manufacturers, combining branded and private-label supply. This dual model creates recurring volume contracts, diversification of end markets and manufacturing scale, supporting steadier demand and margin resilience over months.
Negative Factors
Elevated leverage
A debt-to-equity ratio near 1.5x limits financial flexibility and raises refinancing and interest-rate exposure. Elevated leverage can constrain capital expenditures, dividend policy or strategic investments if demand softens, making the company more sensitive to cyclical pressures over several quarters.
Read all positive and negative factors
Positive Factors
Negative Factors
Diversified revenue streams
Albaad's business spans finished disposable hygiene products and nonwoven materials sold to manufacturers, combining branded and private-label supply. This dual model creates recurring volume contracts, diversification of end markets and manufacturing scale, supporting steadier demand and margin resilience over months.
Read all positive factors
Albaad (ALBA) vs. iShares MSCI Israel ETF (EIS)
Market Cap
₪569.68M
Dividend Yield3.09%
Average Volume (3M)16.36K
Price to Earnings (P/E)9.6
Beta (1Y)0.60
Revenue Growth1.75%
EPS Growth5.26%
CountryIL
Employees1,670
SectorConsumer Defensive
Sector Strength42
IndustryHousehold & Personal Products
Share Statistics
EPS (TTM)93.80
Shares Outstanding18,647,507
10 Day Avg. Volume13,562
30 Day Avg. Volume16,359
Financial Highlights & Ratios
PEG Ratio0.17
Price to Book (P/B)1.42
Price to Sales (P/S)0.38
P/FCF Ratio11.92
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Albaad Business Overview & Revenue Model
Company Description
Albaad Massuot Yitzhak Ltd produces and sells wipes worldwide. It offers cleaning hand wipes including disinfecting and antibacterial wipes; cosmetic wipes, such as facial care, body, and feet care wipes; feminine hygienic product, which include t...
How the Company Makes Money
Albaad makes money primarily by manufacturing and selling disposable hygiene products and nonwoven materials. Revenue is generated from (1) sales of finished hygiene products (e.g., baby diapers, adult incontinence products, and related disposable...
Albaad Financial Statement Overview
Summary
Income Statement
72
Positive
Balance Sheet
54
Neutral
Cash Flow
58
Neutral
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.76B | 1.72B | 1.71B | 1.45B | 1.49B |
| Gross Profit | 349.10M | 347.93M | 344.37M | 235.00M | 270.70M |
| EBITDA | 214.77M | 192.42M | 176.03M | 78.18M | 192.56M |
| Net Income | 69.69M | 44.88M | 30.23M | -35.12M | -20.34M |
Balance Sheet | |||||
| Total Assets | 1.50B | 1.51B | 1.58B | 1.60B | 1.57B |
| Cash, Cash Equivalents and Short-Term Investments | 10.81M | 25.16M | 19.13M | 27.19M | 18.24M |
| Total Debt | 702.17M | 712.92M | 829.03M | 836.53M | 802.11M |
| Total Liabilities | 1.02B | 1.07B | 1.18B | 1.24B | 1.14B |
| Stockholders Equity | 474.19M | 426.68M | 394.08M | 346.83M | 430.25M |
Cash Flow | |||||
| Free Cash Flow | 56.34M | 101.60M | 120.98M | -67.58M | -38.08M |
| Operating Cash Flow | 127.49M | 152.50M | 233.23M | 18.57M | 52.58M |
| Investing Cash Flow | -101.94M | -9.51M | -110.94M | -30.36M | -170.24M |
| Financing Cash Flow | -40.28M | -135.56M | -134.49M | 20.46M | 103.68M |
Albaad Technical Analysis
Negative
3634.00
Price Trends
3310.44
Negative
3188.62
Negative
2722.74
Positive
Market Momentum
-29.24
Negative
38.51
Neutral
46.43
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:ALBA, the sentiment is Negative. The current price of 3634 is above the 20-day moving average (MA) of 3172.65, above the 50-day MA of 3310.44, and above the 200-day MA of 2722.74, indicating a neutral trend. The MACD of -29.24 indicates Negative momentum. The RSI at 38.51 is Neutral, neither overbought nor oversold. The STOCH value of 46.43 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IL:ALBA.
Albaad Peers Comparison
UnderperformOutperform
Sector (62)
IL:ALBA
Albaad
3,055.00
1,484.34
94.50%
IL:SANO1
Sano
39,000.00
8,534.83
28.02%
IL:AMRK
Amir Mark.
3,594.00
533.69
17.44%
IL:AVIV
Aviv
2,314.00
587.30
34.01%
IL:OVRS
Overseas
576.00
148.81
34.83%
IL:LSCO
Lesico
427.90
78.29
22.39%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.